Ingrid Choong - Aug 30, 2023 Form 3 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
Chief Business Officer
Signature
/s/ James Vollins, Attorney-in-Fact for Ingrid C. Choong
Stock symbol
EIGR
Transactions as of
Aug 30, 2023
Transactions value $
$0
Form type
3
Date filed
9/5/2023, 09:35 PM
Next filing
Sep 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EIGR Common Stock 31.1K Aug 30, 2023 Direct F1
holding EIGR Common Stock 2.4K Aug 30, 2023 By Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 5.25K $1.37 Direct F3
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 7.49K $15.89 Direct F3
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 13.2K $11.75 Direct F3
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 25K $9.50 Direct F3
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 17.5K $14.31 Direct F3
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 10K $10.25 Direct F4
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 35K $5.60 Direct F5
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 60K $9.99 Direct F6
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 17.5K $8.15 Direct F7
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 98K $5.10 Direct F8
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 25.8K $1.37 Direct F9
holding EIGR Stock Option (Right to Buy) Aug 30, 2023 Common Stock 98K $1.71 Direct F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3,333 shares underlying Restricted Stock Units ("RSUs") award that will vest in three equal annual installments measured from March 12, 2021, and 10,666 shares underlying RSUs award that will vest in three equal annual installments measured from March 11, 2022.
F2 These shares are held directly by the Choong-Dragoli Family Trust, for which the Reporting Person serves as co-trustee.
F3 These options are fully vested.
F4 The option vests in equal installments over 48 months measured from September 30, 2019, subject to the Reporting Person's continuous service as of each such date.
F5 The option vests in equal installments over 48 months measured from March 12, 2020, subject to the Reporting Person's continuous service as of each such date.
F6 The option vests in equal installments over 48 months measured from March 12, 2021, subject to the Reporting Person's continuous service as of each such date.
F7 The option vests in equal installments over 36 months measured from July 29, 2021, subject to the Reporting Person's continuous service as of each such date.
F8 The option vests in equal installments over 48 months measured from March 11, 2022, subject to the Reporting Person's continuous service as of each such date.
F9 The option vests as to 50% on the first anniversary of the January 26, 2023 grant date, and as to the remaining 50% on June 26, 2024, subject to the Reporting Person's continuous service as of each such date. The option vests in full upon a change in control of the Issuer.
F10 The option vests in equal installments over 48 months measured from March 1, 2023, subject to the Reporting Person's continuous service as of each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney